Liver complications of total parenteral nutrition: the latest therapeutic strategies

[1] Chowdary KV, Reddy PN. Parenteral nutrition: Revisited. Indian J Anaesth. 2010; 54: 95–103. ChowdaryKV ReddyPN Parenteral nutrition: Revisited Indian J Anaesth 2010 54 95 103 Search in Google Scholar

[2] Stueck AE. Intestinal failure-associated liver disease: Risks and regression. Liver Int. 2018; 38: 35–37. StueckAE Intestinal failure-associated liver disease: Risks and regression Liver Int 2018 38 35 37 Search in Google Scholar

[3] Tillman EM. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract. 2013; 28: 30–39. TillmanEM Review and clinical update on parenteral nutrition-associated liver disease Nutr Clin Pract 2013 28 30 39 Search in Google Scholar

[4] Mitra A, Ahn J. Liver disease in patients on total parenteral nutrition. Clin Liver Dis. 2017; 21: 687–695. MitraA AhnJ Liver disease in patients on total parenteral nutrition Clin Liver Dis 2017 21 687 695 Search in Google Scholar

[5] Lloyd DA, Gabe SM. Managi liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66: 530–538. LloydDA GabeSM Managi liver dysfunction in parenteral nutrition Proc Nutr Soc 2007 66 530 538 Search in Google Scholar

[6] Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012; 15: 421–431. ReimannF TolhurstG GribbleFM G-protein-coupled receptors in intestinal chemosensation Cell Metab 2012 15 421 431 Search in Google Scholar

[7] Furness JB. Integrated neural and endocrine control of gastrointestinal function. Adv Exp Med Biol. 2016; 891: 159–173. FurnessJB Integrated neural and endocrine control of gastrointestinal function Adv Exp Med Biol 2016 891 159 173 Search in Google Scholar

[8] Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes Obes Metab. 2018; 20 Suppl 1: 5–21. NauckMA MeierJJ Incretin hormones: Their role in health and disease Diabetes Obes Metab 2018 20 Suppl 1 5 21 Search in Google Scholar

[9] Wales PW, Allen N, Worthington P, George D, Compher C, the American Society for Parenteral and Enteral Nutrition, Teitelbaum D. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. J Parenter Enteral Nutr. 2014; 38: 538–557. WalesPW AllenN WorthingtonP GeorgeD CompherC the American Society for Parenteral and Enteral Nutrition TeitelbaumD A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease J Parenter Enteral Nutr 2014 38 538 557 Search in Google Scholar

[10] Cao X, Feng F, Liu X, Sun C, Yang X, Fang Y, Li S. Exogenous secretin improves parenteral nutrition-associated liver disease in rats. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70: 430–435. CaoX FengF LiuX SunC YangX FangY LiS Exogenous secretin improves parenteral nutrition-associated liver disease in rats Journal of Pediatric Gastroenterology and Nutrition 2020 70 430 435 Search in Google Scholar

[11] Olveira G, Tapia MJ, Ocón J, Cabrehas-Gomez C, Ballesteros-Pomar MD, Vidal-Casariego A, Arraiza-Irigoyen C, Olivares J, Conde-Carcia MC, Garcia-Manzanares A, et al. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition). Nutrition. 2015; 31: 58–63. OlveiraG TapiaMJ OcónJ Cabrehas-GomezC Ballesteros-PomarMD Vidal-CasariegoA Arraiza-IrigoyenC OlivaresJ Conde-CarciaMC Garcia-ManzanaresA Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: a multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition) Nutrition 2015 31 58 63 Search in Google Scholar

[12] McCulloch A, Bansiya V, Woodward JM. Addition of insulin to parenteral nutrition for control of hyperglycemia. JPEN J Parenter Enteral Nutr. 2018; 42: 846–854. McCullochA BansiyaV WoodwardJM Addition of insulin to parenteral nutrition for control of hyperglycemia JPEN J Parenter Enteral Nutr 2018 42 846 854 Search in Google Scholar

[13] Lou PH, Lucchinetti E, Wawrzyniak P, Morsy Y, Wawrzyniak M, Scharl M, Kramer S, Rogler G, Herberger M, Zaugg M. Choice of lipid emulsion determines inflammation of the gut-liver axis, incretin profile, and insulin signaling in a murine model of total parenteral. Mol Nutr Food Res. 2021; 65: e2000412. LouPH LucchinettiE WawrzyniakP MorsyY WawrzyniakM ScharlM KramerS RoglerG HerbergerM ZauggM Choice of lipid emulsion determines inflammation of the gut-liver axis, incretin profile, and insulin signaling in a murine model of total parenteral Mol Nutr Food Res 2021 65 e2000412 Search in Google Scholar

[14] Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007; 117: 24–32. DruckerDJ The role of gut hormones in glucose homeostasis J Clin Invest 2007 117 24 32 Search in Google Scholar

[15] Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007; 87: 1409–1439. HolstJJ The physiology of glucagon-like peptide 1 Physiol Rev 2007 87 1409 1439 Search in Google Scholar

[16] Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859–904. SekirovI RussellSL AntunesLC FinlayBB Gut microbiota in health and disease Physiol Rev 2010 90 859 904 Search in Google Scholar

[17] De Minicis S, Rychlicki C, Agostinelli L, Saccomanna S, Candelaresi C, Trozzi L, Mingarelli E, Facinella B, Magi G, Palmieri C, et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology. 2014; 59: 1738–1749. De MinicisS RychlickiC AgostinelliL SaccomannaS CandelaresiC TrozziL MingarelliE FacinellaB MagiG PalmieriC Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice Hepatology 2014 59 1738 1749 Search in Google Scholar

[18] Pierre JF. Gastrointestinal immune and microbiome changes during parenteral nutrition. Am J Physiol Gastrointest. Liver Physiol. 2017; 312: G246–G256. PierreJF Gastrointestinal immune and microbiome changes during parenteral nutrition Am J Physiol Gastrointest. Liver Physiol 2017 312 G246 G256 Search in Google Scholar

[19] Zaloga GP. Lipid administration, and liver disease during parenteral nutrition. JPEN J Parenter Enteral Nutr. 2015; 39: 39S–60S. ZalogaGP Lipid administration, and liver disease during parenteral nutrition JPEN J Parenter Enteral Nutr 2015 39 39S 60S Search in Google Scholar

[20] Wildhaber BE, Yang H, Spencer AU, Drongowski RA, Teitelbaum DH. Lack of enteral nutrition—Effects on the intestinal immune system. J Surg Res. 2005; 123: 8–16. WildhaberBE YangH SpencerAU DrongowskiRA TeitelbaumDH Lack of enteral nutrition—Effects on the intestinal immune system J Surg Res 2005 123 8 16 Search in Google Scholar

[21] Cerovic V, Bain CC, Mowat AM, Milling SW. Intestinal macrophages and dendritic cells: What's the difference? Trends Immunol. 2014; 35: 270–277. CerovicV BainCC MowatAM MillingSW Intestinal macrophages and dendritic cells: What's the difference? Trends Immunol 2014 35 270 277 Search in Google Scholar

[22] Ochi T, Feng Y, Kitamoto S, Nagao-Kitamoto H, Kuffa P, Atarashi K, Honda K, Teitelbaum DH, Kamada N. Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine. Sci Rep. 2016; 6: 27634. OchiT FengY KitamotoS Nagao-KitamotoH KuffaP AtarashiK HondaK TeitelbaumDH KamadaN Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine Sci Rep 2016 6 27634 Search in Google Scholar

[23] Lespine A, Fernandez Y, Periquet B, Galinier A, Garcia J, Anglade F, Ghisolfi J, Thouvenot JP. Total parenteral nutrition decreases liver oxidative metabolism and antioxidant defenses in healthy rats: comparative effect of dietary olive and soybean oil. JPEN J Parenter Enteral Nutr. 2001; 25: 52–59. LespineA FernandezY PeriquetB GalinierA GarciaJ AngladeF GhisolfiJ ThouvenotJP Total parenteral nutrition decreases liver oxidative metabolism and antioxidant defenses in healthy rats: comparative effect of dietary olive and soybean oil JPEN J Parenter Enteral Nutr 2001 25 52 59 Search in Google Scholar

[24] Rochling FA. Intravenous lipid emulsions in the prevention and treatment of liver disease in intestinal failure. Nutrients. 2021; 13: 895. RochlingFA Intravenous lipid emulsions in the prevention and treatment of liver disease in intestinal failure Nutrients 2021 13 895 Search in Google Scholar

[25] Gabe SM. Lipids and liver dysfunction in patients receiving parenteral nutrition. Curr Opin Clin Nutr Metabol Care. 2013; 16: 150–155. GabeSM Lipids and liver dysfunction in patients receiving parenteral nutrition Curr Opin Clin Nutr Metabol Care 2013 16 150 155 Search in Google Scholar

[26] Xu ZW, Li YS. Pathogenesis and treatment of parenteral nutrition-associated liver disease. Hepatobiliary Pancreat Dis Int. 2012; 11: 586–593. XuZW LiYS Pathogenesis and treatment of parenteral nutrition-associated liver disease Hepatobiliary Pancreat Dis Int 2012 11 586 593 Search in Google Scholar

[27] Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schutz T, Plauth M. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020; 39: 3533–3562. BischoffSC BernalW DasarathyS MerliM PlankLD SchutzT PlauthM ESPEN practical guideline: Clinical nutrition in liver disease Clin Nutr 2020 39 3533 3562 Search in Google Scholar

[28] Lidder PG, Lewis S. Perioperative and postoperative nutrition. Hosp Med. 2004; 65: 717–720. LidderPG LewisS Perioperative and postoperative nutrition Hosp Med 2004 65 717 720 Search in Google Scholar

[29] Norsa L, Nicastro E, Di Giorgio A, Lacaille F, D'Antiga L. Prevention and treatment of intestinal failure-associated liver disease in children. Nutrients. 2018; 10: 664. NorsaL NicastroE Di GiorgioA LacailleF D'AntigaL Prevention and treatment of intestinal failure-associated liver disease in children Nutrients 2018 10 664 Search in Google Scholar

[30] Demehri FR, Stephens L, Herrman E, West B, Mehringer A, Arnold MA, Brown PI, Teitelbaum DH. Enteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis. J Pediatr Surg. 2015; 50: 131–135. DemehriFR StephensL HerrmanE WestB MehringerA ArnoldMA BrownPI TeitelbaumDH Enteral autonomy in pediatric short bowel syndrome: predictive factors one year after diagnosis J Pediatr Surg 2015 50 131 135 Search in Google Scholar

[31] Hwang T, Lue M, Chen L. Early use of cyclic TPN prevents further deterioration if liver functions for the TPN patient with impaired liver function. Hepatogastroenterology. 2004; 47: 1347–1350. HwangT LueM ChenL Early use of cyclic TPN prevents further deterioration if liver functions for the TPN patient with impaired liver function Hepatogastroenterology 2004 47 1347 1350 Search in Google Scholar

[32] Calder P. Hot topics in parenteral nutrition: Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc. 2009; 68: 252–260. CalderP Hot topics in parenteral nutrition: Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults Proc Nutr Soc 2009 68 252 260 Search in Google Scholar

[33] Mundi M, Salonen B, Bonnes S. Home parenteral nutrition: fat emulsions and potential complications. Nutr Clin Pract. 2016; 31: 629–641. MundiM SalonenB BonnesS Home parenteral nutrition: fat emulsions and potential complications Nutr Clin Pract 2016 31 629 641 Search in Google Scholar

[34] Bharadwaj S, Gohel T, Deen OJ, DeChicco R, Shatnawei A. Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease. Gastroenterol Rep (Oxf). 2015; 3: 110–114. BharadwajS GohelT DeenOJ DeChiccoR ShatnaweiA Fish oil-based lipid emulsion: current updates on a promising novel therapy for the management of parenteral nutrition-associated liver disease Gastroenterol Rep (Oxf) 2015 3 110 114 Search in Google Scholar

[35] Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111: 611–616. HellerAR RosselT GottschlichB TiebelO MenschikowskiM LitzRJ ZimmermannT KochT Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients Int J Cancer 2004 111 611 616 Search in Google Scholar

[36] Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525–532. CavicchiM BeauP CrennP DegottC MessingB Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure Ann Intern Med 2000 132 525 532 Search in Google Scholar

[37] Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Sharif MRA, Puder M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011; 46: 666–673. MeiselJA LeHD de MeijerVE NoseV GuraKM MulkernRV SharifMRA PuderM Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model J Pediatr Surg 2011 46 666 673 Search in Google Scholar

[38] El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, Setchell KD, Karpen SJ, Sokol RJ. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med. 2013; 5: 137. El KasmiKC AndersonAL DevereauxMW VuePM ZhangW SetchellKD KarpenSJ SokolRJ Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease Sci Transl Med 2013 5 137 Search in Google Scholar

[39] Mateu de Antonio J, Florit-Sureda M. Effects unrelated to anti-inflammation of lipid emulsions containing fish oil in parenteral nutrition for adult patients, Nutr Hosp. 2017; 34: 193–203. Mateu de AntonioJ Florit-SuredaM Effects unrelated to anti-inflammation of lipid emulsions containing fish oil in parenteral nutrition for adult patients Nutr Hosp 2017 34 193 203 Search in Google Scholar

[40] Ng K, Stoll B, Chacko S, de Pipaon MS, Lauridsen C, Gray M, Squires EJ, Marini J, Zamora IJ, Olutoye OO. Vitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs. JPEN J Parenter Enteral Nutr. 2016; 40: 656–671. NgK StollB ChackoS de PipaonMS LauridsenC GrayM SquiresEJ MariniJ ZamoraIJ OlutoyeOO Vitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs JPEN J Parenter Enteral Nutr 2016 40 656 671 Search in Google Scholar

[41] Guthrie G, Stoll B, Chacko S, Lauridsen C, Plat J, Burrin D. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets. Am J Physiol Gastrointest Liver Physiol. 2020; 318: G41–G52. GuthrieG StollB ChackoS LauridsenC PlatJ BurrinD Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets Am J Physiol Gastrointest Liver Physiol 2020 318 G41 G52 Search in Google Scholar

[42] Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology; 22: 1399–1403. BuchmanAL DubinMD MoukarzelAA JendenDJ RochM RiceKM GornbeinJ AmentME Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation Hepatology 22 1399 1403 Search in Google Scholar

[43] Matsukubo M, Yano K, Kaji T, Sugita K, Onishi S, Harumatsu T, Nagano A, Matsui M, Murakami M, Yamada K. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model. Pediatr Surg Int. 2021; 37: 353–361. MatsukuboM YanoK KajiT SugitaK OnishiS HarumatsuT NaganoA MatsuiM MurakamiM YamadaK The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model Pediatr Surg Int 2021 37 353 361 Search in Google Scholar

[44] Feng Y, Demehri FR, Xiao W, Tsai Y, Jones J, Brindley CD, Treadgill DW, Holst JJ, Hartmann B, Barrett TA, et al. Interdependency of EGF and GLP-2 signaling in attenuating mucosal atrophy in a mouse model of parenteral nutrition. Cell Mol Gastroenterol Hepatol. 2017; 3: 447–468. FengY DemehriFR XiaoW TsaiY JonesJ BrindleyCD TreadgillDW HolstJJ HartmannB BarrettTA Interdependency of EGF and GLP-2 signaling in attenuating mucosal atrophy in a mouse model of parenteral nutrition Cell Mol Gastroenterol Hepatol 2017 3 447 468 Search in Google Scholar

[45] Ceulemans LJ, Verbeke L, Decuypere JP, Farre R, De Hertogh G, Lenaerts K, Jochmans I, Monbaliu D Nevens F, Tack J, et al. Farnesoid X receptor activation attenuates intestinal ischemia reperfusion injury in rats. PLoS One. 2017; 12: e0169331. CeulemansLJ VerbekeL DecuypereJP FarreR De HertoghG LenaertsK JochmansI Monbaliu D NevensF TackJ Farnesoid X receptor activation attenuates intestinal ischemia reperfusion injury in rats PLoS One 2017 12 e0169331 Search in Google Scholar

[46] Liu Y, Xiao Y, Chen S, Tian X, Wang W, Wang Y, Cai W. The farnesoid X receptor agonist tropifexor prevents liver damage in parenteral nutrition-fed neonatal piglets. J Pediatr Gastroenterol Nutr. 2021; 73: e11–e19. LiuY XiaoY ChenS TianX WangW WangY CaiW The farnesoid X receptor agonist tropifexor prevents liver damage in parenteral nutrition-fed neonatal piglets J Pediatr Gastroenterol Nutr 2021 73 e11 e19 Search in Google Scholar

[47] Morin G, Guiraut C, Perez Marcogliese M, Mohamed I, Lavoie JC. Glutathione supplementation of parenteral nutrition prevents oxidative stress and sustains protein synthesis in guinea pig model. Nutrients. 2019. 3; 11: 2063. MorinG GuirautC Perez MarcoglieseM MohamedI LavoieJC Glutathione supplementation of parenteral nutrition prevents oxidative stress and sustains protein synthesis in guinea pig model Nutrients 2019 3 11 2063 Search in Google Scholar

[48] Song E, Nagarapu A, van Nispen J, Armstrong A, Manithody C, Murali V, Voigt M, Samaddar A, Hutchinson C, Jain S, Roenker J, Krebs J, Jain AK. Carbamazepine mitigates parenteral nutrition–associated liver disease in a novel ambulatory piglet model. JPEN J Parenter Enteral Nut. 2022 Aug; 46: 1384–1392. SongE NagarapuA van NispenJ ArmstrongA ManithodyC MuraliV VoigtM SamaddarA HutchinsonC JainS RoenkerJ KrebsJ JainAK Carbamazepine mitigates parenteral nutrition–associated liver disease in a novel ambulatory piglet model JPEN J Parenter Enteral Nut 2022 Aug 46 1384 1392 Search in Google Scholar

[49] Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003; 124: 1111–1134. BuchmanAL ScolapioJ FryerJ AGA technical review on short bowel syndrome and intestinal transplantation Gastroenterology 2003 124 1111 1134 Search in Google Scholar

[50] Fryer J, Pellar S, Ormond D, Koffron A, Abecessis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 2003; 9: 748–753. FryerJ PellarS OrmondD KoffronA AbecessisM Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants Liver Transpl 2003 9 748 753 Search in Google Scholar